Complete PSMA-PET Solutions: Advancing the Standard of Care

Learn More

Learn What Invicro's IQ Analytics Platform Can Do

Learn More

Supporting Clinical Research With Core Lab Excellence

Learn More

Maximize Your Tissue's Potential

Learn How

Gain New Insights in Early Drug Discovery

Learn More

PSMA-PET Webinar Series

Invicro’s PSMA-PET webinar series features industry-leading KOL’s who discuss the role imaging biomarkers play in the discovery and development of life-changing drugs for prostate cancer.

PSMA is a popular target for both imaging to identify the presence of prostate cancer and to deliver drugs directly to the cancerous cells. A PSMA-PET scan is a powerful molecular imaging technique that can accurately localize prostate cancer and assess tumors’ level of PSMA expression.

Learn more by downloading our webinar series below.

DOWNLOAD NOW

SUPPORTING
ALL DRUG
DISCOVERY &
DEVELOPMENT
PHASES

DRUG
DISCOVERY
EARLY
CLINICAL
LATE
PHASE
  • 3,000+ Research Trials Managed
  • 450+ Clinical Trials Managed
  • ~40,000,000 (DICOM) Images Processed
  • 800+ Molecules Labeled

CNS Webinar Series

Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.

Watch Now

Oncology Webinar Series

Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.

Watch Now